Gaviscon

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Alginic acid 500mg;  ;  ; Aluminium hydroxide gel dried 100mg;  ;  ;  ; Magnesium trisilicate hydrate 25mg; Sodium bicarbonate 170mg

Commercializzato da:

Reckitt Benckiser (New Zealand) Limited

INN (Nome Internazionale):

Alginic acid 500 mg

Forma farmaceutica:

Chewable tablet

Composizione:

Active: Alginic acid 500mg     Aluminium hydroxide gel dried 100mg       Magnesium trisilicate hydrate 25mg Sodium bicarbonate 170mg Excipient: Calcium carbonate Magnesium stearate Mannitol Peppermint oil Polyvidone 30 Saccharin sodium Vanillin Xylitol

Confezione:

Blister pack, 1x6 Sample pack., 6 tablets

Classe:

General sale

Tipo di ricetta:

General sale

Prodotto da:

FMC Biopolymer AS

Dettagli prodotto:

Package - Contents - Shelf Life: Blister pack, Sample pack - 6 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, - 24 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, - 48 tablets - 36 months from date of manufacture stored at or below 30°C - Tablet container, plastic, - 60 tablets - 36 months from date of manufacture stored at or below 30°C

Data dell'autorizzazione:

1995-01-27